You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Former SAC portfolio manager Martoma indicted

NEW YORK — A former hedge fund portfolio manager was indicted Friday for securities fraud in connection with what prosecutors said could be the most lucrative insider trading scheme to date.

A federal grand jury in New York indicted Mathew Martoma on three counts of securities fraud and conspiracy to commit securities fraud.

Continue reading below

Martoma worked for an affiliate of SAC Capital Advisors. SAC, based in Stamford, Conn., is owned by Steven A. Cohen, one of the world’s richest men.

Martoma, of Boca Raton, Fla., was arrested in November by the FBI in connection with the scheme that allegedly involved an arrangement between 2006 and 2008 to obtain secret, advance results of tests on an experimental Alzheimer’s drug.

According to the indictment, Martoma made trades in Elan Corp. PLC and Wyeth, pharmaceutical companies that were partners in the development of the experimental drug, using confidential information about a drug trial.

The trades allegedly included selling nearly all of the $700 million worth of shares the hedge fund held in both companies just before negative news of trial results were made public.

The trades allegedly helped SAC gain profits and avoid losses totaling $276 million. Martoma got a bonus of $9.3 million as a result of the illegal scheme, according to the indictment.

SAC is owned by Steven A. Cohen, one of the world’s richest men.

Quote Icon

The indictment follows an earlier criminal complaint filed in November.

‘‘Though disappointing, today’s events come as no surprise,’’ Martoma’s lawyer Charles Stillman said in a statement. ‘‘The simple fact is that Mathew Martoma did not trade on inside information, is innocent of all these charges, and we look forward to his ultimate vindication.’’

Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.